Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$86,171,277
-$13,799,948 QoQ
Shares Held
92,880
-32.2% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
1.70%
of 13F equity value
Holder Rank
#44
of 505 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 26%
Shared 0%
None 74%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ORBIMED ADVISORS LLC holds $3,639,640,835 across 90 Biotechnology names. ARGX ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EWTX |
Edgewise Therapeutics, Inc.
|
15,518,492 | $630,516,329 | |
| 2 | ELVN |
Enliven Therapeutics, Inc.
|
6,776,632 | $343,914,074 | |
| 3 | MBX |
MBX Biosciences, Inc.
|
3,428,736 | $189,266,227 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
2,209,400 | $118,578,498 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
2,555,877 | $112,433,029 | |
| 6 | CRVS |
Corvus Pharmaceuticals, Inc.
|
7,165,006 | $107,045,189 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
3,027,328 | $105,169,374 | |
| 8 | ARGX |
Argenx SE
This page
|
92,880 | $86,171,277 |
All Filings in ARGX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,171,277 | 92,880 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $99,971,225 | 136,900 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $122,778,700 | 146,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $127,081,588 | 172,300 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $114,653,760 | 208,000 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $122,338,495 | 206,700 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $116,665,500 | 189,700 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $110,855,360 | 204,500 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $89,921,364 | 209,100 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $59,687,952 | 151,600 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $32,184,378 | 84,600 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $16,027,138 | 32,600 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $12,705,198 | 32,600 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,579,810 | 44,500 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $6,137,046 | 16,200 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $95,217,585 | 269,700 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $73,502,720 | 194,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $53,539,638 | 169,800 | Shares | Sole | 2022-05-16 | |
| 2020-03-31 | $3,766,292 | 28,591 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||